Tolentino, Ruperta .
HRN: 11-19-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
CEFTRIAXONE 1G (VIAL)
06/04/2026
06/10/2026
IV
2G
Od
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes